Fast homogeneous assay for plasma procarboxypeptidase U

Clinical Chemistry and Laboratory Medicine

Volumn 39, Issue 9, 2001, Pages 806-810

  Schatteman, K A ^a   Goossens, F J ^a   Leurs, J ^a   Kasahara, Y ^a   Scharpe S S ^a   Hendriks, D F ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Assay; CPU = carboxypeptidase U; Fibrinolysis; TAFI = thrombin activatable fibrinolysis inhibitor

Indexed keywords

4 AMINOPHENAZONE; 4 HYDROXYBENZOIC ACID; AMINOACYLASE; DYE; ENZYME PRECURSOR; GLYCINE; HIPPURIC ACID DERIVATIVE; IMINE; QUINONE DERIVATIVE; SODIUM IODATE; THROMBIN; THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR; THROMBOMODULIN; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN DEGRADATION;

ADULT; AGED; AMIDOHYDROLASES; CARBOXYPEPTIDASE U; ENZYME ACTIVATION; FEMALE; FIBRINOLYSIS; HIPPURATES; HUMANS; MALE; MIDDLE AGED; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; THROMBIN; THROMBOMODULIN;

EID: 0034802376     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2001.133     Document Type: Article

References (26)

1. Characterization of a carboxypeptidase in human serum distinct from carboxypeptidase N
2. A labile enzyme in fresh human serum that interferes with the assay of carboxypeptidase N
3. Purification and characterization of TAFI, a thrombin-activable fibrinolysis inhibitor
4. Basic carboxypeptidases: Regulators of hormone activity
5. The plasma carboxypeptidases and the regulation of the plasminogen system
6. Carboxypeptidase U at the interface between coagulation and fibrinolysis
7. Inducible carboxypeptidase activity
8. Plasma carboxypeptidases as regulators of the plasminogen system
9. Thrombin-mediated activation of factor XI results in a thrombin-activatable fibrinolysis inhibitor-dependent inhibition of fibrinolysis
10. Plasma TAFI levels influence the clot lysis time in healthy individuals in the presence of an intact intrinsic pathway of coagulation
11. Immunological assay for the determination of procarboxypeptidase U antigen levels in human plasma
12. Assay of procarboxypeptidase U, a novel determinant of the fibrinolytic cascade, in human plasma
13. Proteolytic activation of purified human procarboxypeptidase U
14. Deacetylation of PS-5, a new beta-lactam compound. II. Separation and purification of L- and D-amino acid acylases from Pseudomonas sp. 1158
15. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
16. Carboxypeptidase U, a plasma carboxypeptidase with high affinity for plasminogen
17. Carboxypeptidase N: Colorimetric assay using a new substrate
18. Partial characterization of a new arginine carboxypeptidase from human serum
19. Purification and characterization of a new arginine carboxypeptidase in human serum
20. Isolation, molecular cloning, and partial characterization of a novel carboxypeptidase B from human serum
21. The profibrinolytic effect of activated protein C in clots formed from plasma is TAFI-dependent
22. Activation of plasma procarboxypeptidase U in different mammalian species points to a conserved pathway of fibrinolysis
23. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: A randomized cross-over study of two low-dose oral contraceptives
24. Arginine carboxypeptidase (CPR) in human plasma determined with sandwich ELISA
25. Colorimetric assay for carboxypeptidase N in serum